"Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome" by Annette C Reboli

Article

Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome

BMC Infectious Diseases (2011)

Annette C Reboli, Rowan University
Andrew F Shorr, MedStar Washington Hospital Center
Coleman Rotstein, University Health Network
Peter G Pappas, University of Alabama at Birmingham
Daniel H Kett, University of Miami
Haran T Schlamm, Pfizer
Arlene L Reisman, Pfizer
Pinaki Biswas, Pfizer
Thomas J Walsh, NewYork–Presbyterian Hospital

Link

Disciplines

Publication Date

January 12, 2011

DOI

10.1186/1471-2334-11-261

Citation Information

Annette C Reboli, Andrew F Shorr, Coleman Rotstein, Peter G Pappas, et al.. "Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome" BMC Infectious Diseases Vol. 11 Iss. 1 (2011) p. 261 - 261
Available at: http://works.bepress.com/annette-reboli/20/